secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0001193125-22-295491
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics prices $15.7M public offering of 24.2M shares at $0.62/share
--------------------------------------------------------------------------------

- Priced 24,228,719 shares at $0.6191 per share for gross proceeds of $15.7M.
- Net proceeds expected ~$14.6M after underwriting discounts and estimated expenses.
- Underwriter granted 30-day option to purchase up to 3,634,307 additional shares.
- Proceeds to fund continued development of product candidates and for working capital.
- Offering expected to close on or about December 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119312522295491/0001193125-22-295491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119312522295491/d424988d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-295491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer